29
Participants
Start Date
December 31, 2007
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
ABI-007
ABI-007 will be administered at a dose of 260 mg/m2 over a 30 min IV infusion on day 1 of each 21 day cycle.
Carboplatin
Carboplatin will be administered at a dose of TARGET AUC=5 over a 15 min IV infusion of day 1 of each 21 day cycle.
Gemcitabine
Gemcitabine will be administered at a dose of 800 mg/m2 over a 30 min IV infusion on days 1 and 8 of each 21 day cycle.
Radical Cystectomy
University of Michigan, Ann Arbor
Collaborators (1)
Celgene Corporation
INDUSTRY
University of Michigan Rogel Cancer Center
OTHER